Business and R&D operations, driving change and efficiency, metric based reporting and strategy

For over 18 years, I have worked at the leading edge of transformative health care technologies, including computer assisted surgery, surgical robotics and genetic nanomedicines. After completing an MBA from the University of British Columbia, I directed the commercial operations of Precision NanoSystems, and helped oversee the global launch of its transformative nanomedicine manufacturing technologies. I was also founder and CEO of Ascension Sciences, a preclinical nanoparticle CRO, engaging collaborators globally for the development of leading platforms for insoluble small-molecule APIs.